Insulin resistance and oxidative stress in familial combined hyperlipidemia

Atherosclerosis

Volumn 199, Issue 2, 2008, Pages 384-389

  Martinez Hervas, Sergio ^a   Fandos, Marta ^b   Real, Jose T ^a   Espinosa, Olga ^b   Chaves, F Javier ^a   Saez, Guillermo T ^b   Salvador, Amparo ^b   Cerdá, Concha ^b   Carmena, Rafael ^a   Ascaso, Juan F ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

Author keywords

Atherosclerosis; Familial combined hyperlipidemia; Insulin resistance; Oxidative stress

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; GLUCOSE; GLUTATHIONE; GLUTATHIONE DISULFIDE; INSULIN;

ADULT; AGED; ANTHROPOMETRIC PARAMETERS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERLIPIDEMIA; INSULIN RESISTANCE; MALE; MONONUCLEAR CELL; OXIDATIVE STRESS; PLASMA; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; ATHEROSCLEROSIS; DEOXYGUANOSINE; FEMALE; GLUTATHIONE; GLUTATHIONE DISULFIDE; HUMANS; HYPERLIPIDEMIA, FAMILIAL COMBINED; INSULIN RESISTANCE; LIPIDS; MALE; MIDDLE AGED; OXIDATIVE STRESS;

EID: 47649098616     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.11.023     Document Type: Article

References (31)

1. Goldstein J.L., Hazzard W.R., Schrott G., et al. Hyperlipidemia in coronary heart disease. I. Lipid levels in 500 survivors of myocardial infarction. J Clin Invest 52 (1973) 1533-1543
2. Goldstein J.L., Schrott H.G., Hazzard W.R., et al. Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest 52 (1973) 1544-1568
3. Hazzard W.R., Goldstein J.L., Schrott H.G., et al. Hyperlipidemia in coronary heart disease. III. Evaluation of lipoprotein phenotypes of 156 genetically defined survivors of myocardial infarction. J Clin Invest 52 (1973) 1569-1577
4. Paoletti R., Gotto A.M., and Hajjar D.P. Inflammation in atherosclerosis and implications for therapy. Circulation 109 Suppl. III (2004) 20-26
5. Martinet W., Knaapen M.W., De Meyer G.R., et al. Elevated levels of oxidative DNA damage and DNA repair enzymes in human atherosclerotic plaques. Circulation 106 (2002) 927-932
6. Ascaso J.F., Merchante A., Lorente R.I., et al. A study of insulin resistance, using the minimal model, in non-diabetic familial combined hyperlipidemic patients. Metabolism 47 (1998) 508-513
7. Ascaso J.F., Sales J., Merchante A., et al. Influence of obesity on plasma lipoproteins, glycaemia and insulinaemia in patients with Familial combined hyperlipidaemia. Int J Obes 21 (1997) 360-366
8. Ascaso J.F., Lorente R., Merchante A., et al. Insulin resistance in patients with familial combined hyperlipidemia and ischemic heart disease. Am J Cardiol 80 (1997) 1484-1487
9. Papaharalambus C.A., and Griendling K.K. Basic mechanisms of oxidative stress and reactive oxygen species in cardiovascular injury. Trends Cardiovasc Med 17 (2007) 48-54
10. Smedly L.A., Tonnesen M.G., Sandhaus R.A., et al. Neutrophil-mediated injury to endothelial cells: enhancement by endotoxin and essential role of neutrophil elastase. J Clin Invest 77 (1986) 1233-1243
11. Weiss S.J. Tissue destruction by neutrophils. N Engl J Med 320 (1989) 365-376
12. Nourooz-Zadeh J., Smith C.C., and Betteridge D.J. Measures of oxidative stress in heterozygous familial hypercholesterolaemia. Atherosclerosis 156 (2001) 435-441
13. Castro-Cabezas M., De Bruin T.W.A., and Erkelens D.W. Familial combined hyperlipidaemia: 1973-1991. Nether J Med 40 (1992) 83-95
14. Ascaso J.F., Romero P., Real J.T., et al. Insulin resistance quantification by fasting insulin plasma values and HOMA index in a non-diabetic population. Med Clin (Barc) 117 (2001) 530-533
15. Oltra A.M., Carbonell F., Tormos C., et al. Antioxidant enzyme activities and the production of MDA and 8-oxo-dG in chronic lymphocytic leukemia. Free Radic Biol Med 30 (2001) 1286-1292
16. Navarro J., Obrador E., Pellicer J.A., et al. Blood glutathione as an index of radiation-induced oxidative stress in mice and humans. Free Radic Biol Med 22 (1997) 1203-1209
17. Muniz P., Valls V., Perez-Broseta C., et al. The role of 8-hydroxy-2′-deoxyguanosine in rifamycin-induced DNA damage. Free Radic Biol Med 18 (1995) 747-755
18. Nebot C., Moutet M., Huet P., et al. Spectrophotometric assay of superoxide dismutase activity based on the activated autoxidation of a tetracyclic catechol. Anal Biochem 214 (1993) 442-451
19. Aebi H. Catalase in vitro. Methods Enzymol 105 (1984) 121-126
20. Paglia D.E., and Valentine W.N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70 (1967) 158-169
21. Heistad D.D. Oxidative stress and vascular disease: 2005 Duff lecture. Arterioscler Thromb Vasc Biol 26 (2006) 689-695
22. Spiekermann S., Landmesser U., Dikalov S., et al. Electron spin resonance characterization of vascular xhantine and NAD(P)H oxidase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation. Circulation 107 (2003) 1383-1389
23. Blankenberg S., Rupprecht H.J., Bickel C., et al. Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease. N Engl J Med 349 (2003) 1595-1604
24. Dalle-Donne I., Rossi R., Colombo R., et al. Biomarkers of oxidative damage in human disease. Clin Chem 52 (2006) 601-623
25. Tsutsui H., Ide T., Shiomi T., et al. 8-oxo-dGTPase, which prevents oxidative stress-induced DNA damage, increases in the mitochondria from failing hearts. Circulation 104 (2002) 2883-2885
26. Andican G., and Burcak G. Oxidative damage to nuclear DNA in streptozotocin-diabetic rat liver. Clin Exp Pharmacol Physiol 32 (2005) 663-666
27. Stephens J.W., Gable D.R., Hurel S.J., et al. Increased plasma markers of oxidative stress are associated with coronary heart disease in males with diabetes mellitus and with 10-year risk in a prospective sample of males. Clin Chem 52 (2006) 446-452
28. Evans J.L., Goldfine I.D., Maddux B.A., et al. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev 23 (2002) 599-622
29. Ceriello A., and Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol 24 (2004) 816-823
30. Urakawa H., Katsuki A., Sumida Y., et al. Oxidative stress is associated with adiposity and insulin resistance in men. J Clin Endocrinol Metab 88 (2003) 4673-4676
31. Dandona P., Aljada A., Chaudhuri A., et al. The potential influence of inflammation and insulin resistance on the pathogenesis and treatment of atherosclerosis-related complications in type 2 diabetes. J Clin Endocrinol Metab 88 (2003) 2422-2429